Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Gains from Sales and Divestitures (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Gains from Sales and Divestitures for 6 consecutive years, with $159150.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 76.05% to $159150.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $159150.0 through Dec 2025, up 76.05% year-over-year, with the annual reading at $159150.0 for FY2025, 76.05% up from the prior year.
  • Gains from Sales and Divestitures hit $159150.0 in Q4 2025 for Eton Pharmaceuticals, up from $84204.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $159150.0 in Q4 2025 to a low of $889.0 in Q2 2025.
  • Historically, Gains from Sales and Divestitures has averaged $76930.8 across 4 years, with a median of $90402.0 in 2024.
  • Biggest YoY gain for Gains from Sales and Divestitures was 76.05% in 2025; the steepest drop was 6.86% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $7595.0 in 2021, then surged by 1103.45% to $91402.0 in 2023, then decreased by 1.09% to $90402.0 in 2024, then soared by 76.05% to $159150.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for ETON at $159150.0 in Q4 2025, $84204.0 in Q3 2025, and $889.0 in Q2 2025.